DNA RNA and Cells

16 Nov 2009 Genta Announces Results of AGENDA Phase 3 Trial of GenasenseĀ® in Patients with Advanced Melanoma
16 Nov 2009 Phase 1/2 Results for Aldagen's ALD-301 Critical Limb Ischemia Clinical Study Presented at AHA
12 Nov 2009 Cequent Files its First IND with FDA: CEQ508, a tkRNAi Drug Candidate in Oncology
11 Nov 2009 Geron Collaborators Publish Data on hESC-Derived Glial Progenitor Cell Therapy in Cervical Spinal Cord Injury
11 Nov 2009 AMT Successful in Preclinical Treatment of DMD
11 Nov 2009 Aastrom to Initiate Second Phase II Clinical Trial for Treatment of Severe Chronic Heart Failure
10 Nov 2009 MOLOGEN applies for clinical study with cell-based gene therapy for renal cancer
09 Nov 2009 Zosano Pharma, Inc. Announces Publication of Positive Phase 2 Study of Its ZP-PTH Patch for Osteoporosis Therapy
06 Nov 2009 Genetix Pharmaceuticals Announces Global Clinical Plans to Treat Adrenoleukodystrophy (ALD)
06 Nov 2009 Oncolytics Biotech Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting
05 Nov 2009 Alnylam Presents New Pre-Clinical Data on RNAi Therapeutics at Oligonucleotides Therapeutics Society (OTS) Meeting
04 Nov 2009 Alnylam and Roche Advance RNAi Therapeutic Collaboration Phase of Landmark 2007 Alliance
04 Nov 2009 MOLOGEN reaches primary end points in MGN1703 study
03 Nov 2009 Idera Pharmaceuticals Presents Preclinical Data on IMO-2125, its Lead Drug Candidate for Chronic Hepatitis C Virus Infection, at Liver Meeting 2009
02 Nov 2009 Alnylam Presents New Pre-Clinical Data on ALN-TTR, an RNAi Therapeutic for the Treatment of Transthyretin-Mediated Amyloidosis
02 Nov 2009 NOXXON Announces Initiation of First-in-Human Clinical Trial with Hematopoietic Stem Cell Mobilizing SpiegelmerĀ® NOX-A12
29 Oct 2009 Heart Disease and Cellular Therapy: Start of Phase III Clinical Trial "PERFECT" Using Autologous CD133+ Bone Marrow Stem Cells
26 Oct 2009 AVI BioPharma Presents Updated Safety Data From Ongoing Systemic Trial of AVI-4658 at 7th Annual Action Duchenne International Conference
22 Oct 2009 Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 113715 in Patients With Type 2 Diabetes
19 Oct 2009 Idera Pharmaceuticals Presents Preclinical Data at ACR/ARHP 2009 Annual Meeting on IMO-3100, a Toll-Like Receptor Antagonist, in Combination with Enbrel(R) in Arthritis Model
19 Oct 2009 StemCells, Inc.'s Neural Stem Cells Show Promise for Treating Age-Related Macular Degeneration
16 Oct 2009 Oxford BioMedica Announces Update on ProSavinĀ® Phase I/II Trial in Parkinsons Disease And Publication of Preclinical Results
14 Oct 2009 California Stem Cell, Inc. and Families of Spinal Muscular Atrophy Announce Completion of Pre-IND Meeting with FDA for Stem Cell-Derived Therapy for the Treatment of Spinal Muscular Atrophy Type I
14 Oct 2009 GlaxoSmithKline and Prosensa form alliance to fight Duchenne Muscular Dystrophy

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up